España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
eFFECTOR Therapeutics
EFTR
OTCEM
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.00020
0.00
0.00%
At close: -
$0.0783
0.08
39050.00%
After Hours: Jul 5, 4:00 PM EDT
Get Report
Comment
eFFECTOR Therapeutics (EFTR) Forecast
News
Earnings
eFFECTOR Therapeutics (EFTR) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for eFFECTOR Therapeutics (OTC:EFTR) Stock
eFFECTOR Therapeutics Stock (OTC: EFTR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, June 26, 2024
eFFECTOR Therapeutics Declared in Default on ...
Benzinga Newsdesk
Monday, June 24, 2024
Dow Jumps 300 Points; Alimera Sciences Shares Spike Higher
Avi Kapoor
Why eFFECTOR Therapeutics (EFTR) Shares Are Down Over 70%
Henry Khederian
EFFECTOR Therapeutics shares are trading lowe...
Benzinga Newsdesk
eFFECTOR Therapeutics To Wind Down Operations...
Benzinga Newsdesk
Tuesday, May 28, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, May 20, 2024
eFFECTOR Therapeutics And Dana-Farber Cancer ...
Benzinga Newsdesk
Thursday, May 09, 2024
eFFECTOR Therapeutics Q1 2024 GAAP EPS $(2.16...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Friday, April 05, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Thursday, April 04, 2024
Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
Avi Kapoor
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings
Avi Kapoor
Cancer-Focused eFFECTOR Therapeutics Shelves Development Of Lung Cancer Candidate After Disappointing Data
Vandana Singh
Dow Jumps Over 100 Points; US Jobless Claims Increase To 221,000
Avi Kapoor
EFFECTOR Therapeutics Shares Resume Trade
Benzinga Newsdesk
EFFECTOR Therapeutics Shares Halted On Circui...
Benzinga Newsdesk
EFFECTOR Therapeutics shares are trading lowe...
Benzinga Newsdesk
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
eFFECTOR Therapeutics Announces Topline Resul...
Benzinga Newsdesk
Trading Halt: Halted at 8:25:00 a.m. ET - Tra...
Benzinga Newsdesk
Thursday, March 28, 2024
HC Wainwright & Co. Reiterates Buy on eFFECTO...
Benzinga Newsdesk
Monday, March 25, 2024
eFFECTOR Therapeutics Cash, Cash Equivalents,...
Benzinga Newsdesk
eFFECTOR Therapeutics Q4 EPS $(3.42) Misses $(1.65) Estimate
Happy Mohamed
Friday, March 08, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Tuesday, February 06, 2024
HC Wainwright & Co. Maintains Buy on eFFECTOR...
Benzinga Newsdesk
Thursday, January 25, 2024
eFFECTOR Therapeutics Announces $15M Register...
Benzinga Newsdesk
Wednesday, January 24, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Friday, January 12, 2024
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Tuesday, January 09, 2024
Dow Tumbles Over 200 Points; US Trade Gap Narrows In November
Avi Kapoor
eFFECTOR Therapeutics shares are trading lowe...
Benzinga Newsdesk
eFFECTOR Therapeutics Announces 1-For-25 Reve...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, January 08, 2024
Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, December 11, 2023
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Friday, December 08, 2023
eFFECTOR Therapeutics Discloses Updated Data From Mid-Stage Breast Cancer Study
Vandana Singh
eFFECTOR Therapeutics Announces New Interim D...
Benzinga Newsdesk
Thursday, November 30, 2023
eFFECTOR Therapeutics 10% Owner Trades $369K In Company Stock
Benzinga Insights
Tuesday, November 28, 2023
eFFECTOR Receives FDA Fast Track Designation ...
Benzinga Newsdesk
Friday, November 24, 2023
Effector Therapeutics Granted European Patent...
Benzinga Newsdesk
Wednesday, November 15, 2023
eFFECTOR Therapeutics To Present New Clinical...
Benzinga Newsdesk
Tuesday, November 14, 2023
HC Wainwright & Co. Reiterates Buy on eFFECTO...
Benzinga Newsdesk
Monday, November 13, 2023
eFFECTOR Therapeutics Q3 EPS $(0.13) Misses $...
Benzinga Newsdesk
Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Why StoneCo Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Tuesday, October 24, 2023
eFFECTOR Therapeutics To Collaborate With The...
Benzinga Newsdesk
Tuesday, September 12, 2023
Board Member at eFFECTOR Therapeutics Acquires Company Stock Options Worth 40,000 Shares
Benzinga Insights
Show More